Troquidazole
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101695This classification denotes an antiprotozoal agent with the molecular formula C14H15N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 41X4FOR202, chemically known as 4-morpholinecarboximidamide, n-(3-nitro-4-quinolinyl)- but generally known as troquidazole, which bears US NIH Compound Identifier 65903. European Medicines Agency schedules Troquidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11347MIG. The term TROQUIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). Most nations schedule troquidazole under HS 29349990 and SITC 51579. As of Q4 2014, TROQUIDAZOLE remains the US FDA Preferred Term for this commodity. Troquidazole bears US NLM identifiers UMLS ID C2700085 and NCI Concept Code C76435. SMILES: O1CCN(CC1)/C(=N/C1C2C(NCC1[N](=O)O)CCCC2)N.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.